Business Insights' Lifestyle Drugs Market Outlook

Key Indications, Epidemiology, and Emergent Drugs

Product Description:

Did you know the European and US markets for skincare had a combined value of $6.6 billion in 2006, and are projected to reach $8.5 billion by 2011?

The market for lifestyle drugs has become one of the most dynamic and commercially attractive sectors in the pharmaceutical industry. With developed markets expected to witness aging demographics as well as continued increases in health awareness, disposable incomes and pharmaceutical branding activity, conditions appear highly favourable for further growth.

Lifestyle Drugs Market Outlook: Key indications, epidemiology and emergent drugs is a new report published by Business Insights that provides a detailed analysis of the latest developments within seven individual lifestyle drug markets. Key industrial trends in the fields of consumer demand and pipeline development are examined, leading players and products within each treatment area are profiled and the market potential of each lifestyle therapy is assessed. This report will also provide a substantial review of reimbursement policies and their impact upon product sales across the seven major markets.

Evaluate the prospects of major lifestyle therapies and identify emerging opportunities in the global market for lifestyle drugs with this new report…

Top five reasons to order your copy today

Assess the market potential of key lifestyle therapies with this report’s detailed analysis of demand and epidemiology for conditions such as Alcohol Dependence, Alopecia, Obesity, Oral Contraception, Sexual Dysfunction, Skin Aging and Smoking Cessation.

Recognize the major issues affecting lifestyle drug revenues across global markets with this report’s examination of consumer spend dynamics and current pricing and reimbursement environments in countries including Japan, France, Germany, Italy, Spain, Canada, Australia, China, the US and the UK.

Identify key success factors within the lifestyle drugs market by benchmarking the successful growth strategies of leading drug developers and technological innovators.

Anticipate future trends and scenarios with in-depth analysis of the main drivers and resistors to market growth in addition to the latest innovations in lifestyle drug development, dosing and delivery.

Evaluate the best methods of obtaining reimbursement and recognition for lifestyle drugs with this report’s comprehensive review of strategic options across the seven major markets.

The report will be delivered as a PDF via e-mail. Orders must be paid in full before shipment. All sales are final; no returns or refunds are permitted with this product. For more information, please call 877/437-4276 or e-mail epharm@hcpro.com

Save money when you purchase multiple copies! Ask your customer service representative about money-saving discounts and bulk orders. Call toll free 800-650-6787 or e-mail customerservice@hcpro.com.
Publisher :  Datamonitor
 
Product Types : Departments :
This special report provides a detailed analysis of the latest developments within seven individual lifestyle drug markets. Key industrial trends in the fields of consumer demand and pipeline development are examined, leading players and products within each treatment area are profiled and the market potential of each lifestyle therapy is assessed. This report will also provide a substantial review of reimbursement policies and their impact upon product sales across the seven major markets.
Email Print
ORDER CODE: BILD
SOURCE CODE: EB83192A
Supplemental Info

Related Products